Agius, L. (2009). Targeting Hepatic Glucokinase in Type 2 Diabetes: Weighing the Benefits and Risks. American Diabetes Association.
Citação norma ChicagoAgius, Loranne. Targeting Hepatic Glucokinase in Type 2 Diabetes: Weighing the Benefits and Risks. American Diabetes Association, 2009.
ציטוט MLAAgius, Loranne. Targeting Hepatic Glucokinase in Type 2 Diabetes: Weighing the Benefits and Risks. American Diabetes Association, 2009.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.